Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib

Neuro Oncol. 2023 Jun 2;25(6):1193-1195. doi: 10.1093/neuonc/noad051.

Jan-Michael Werner¹, Michael M Wollring^{1

2}, Caroline Tscherpel^{1

2}, Elena K Rosen¹, Lisa Werr³, Isabelle Stetter¹, Daniel Rueß⁴, Maximilian I Ruge⁴, Anna Brunn⁵, Abdulkader Al Shughri⁵, Christoph Kabbasch⁶, Gereon R Fink^{1

2}, Karl-Josef Langen^{2

7}, Norbert Galldiks^{1

2

8}

¹ Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
² Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
³ Department of Experimental Pediatric Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁴ Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne,Germany.
⁵ Institute of Neuropathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
⁶ Institure of Radiology, Division of Neuroradiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne,Germany.
⁷ Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.
⁸ Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany.

No abstract available

Keywords: DWI; FET PET glioma; PWI; bevacizumab.

Publication types